de Mendoza C - Search Results

1

Pre-Exposure Prophylaxis for viral infections other than HIV.

Soriano V, Treviño A, de Mendoza C, Moreno-Torres V, Pintos I, Barreiro P, Corral O. Soriano V, et al. Among authors: de mendoza c. Infez Med. 2022 Sep 1;30(3):362-371. doi: 10.53854/liim-3003-5. eCollection 2022. Infez Med. 2022. PMID: 36148176 Free PMC article. Review.

2

False positives for HIV using commercial viral load quantification assays.

de Mendoza C, Holguín A, Soriano V. de Mendoza C, et al. AIDS. 1998 Oct 22;12(15):2076-7. doi: 10.1097/00002030-199815000-00022. AIDS. 1998. PMID: 9814879 No abstract available.

3

Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.

Holguín A, de Mendoza C, Soriano V. Holguín A, et al. Among authors: de mendoza c. Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):256-9. doi: 10.1007/s100960050273. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10385013

4

Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors.

de Mendoza C, Soriano V, González-Lahoz J. de Mendoza C, et al. Eur J Clin Microbiol Infect Dis. 1999 Aug;18(8):604-5. doi: 10.1007/s100960050358. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10517203 No abstract available.

5

Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy.

Barreiro P, de Mendoza C, Soriano V, González-Lahoz J. Barreiro P, et al. Among authors: de mendoza c. AIDS. 2000 Jan 28;14(2):207-8. doi: 10.1097/00002030-200001280-00020. AIDS. 2000. PMID: 10708295 No abstract available.

6

Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodés B, Casas E, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 1999 Nov-Dec;2(6):344-9. J Hum Virol. 1999. PMID: 10774551

7

Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodríguez-Rosado R, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 2000 Nov-Dec;3(6):335-40. J Hum Virol. 2000. PMID: 11100914 Clinical Trial.

8

Monthly cyclic therapy in heavily pretreated HIV-infected patients.

Soriano V, Barreiro P, de Mendoza C, Dona C, González-Lahoz J. Soriano V, et al. Among authors: de mendoza c. AIDS Patient Care STDS. 2001 Apr;15(4):177-9. doi: 10.1089/10872910151133666. AIDS Patient Care STDS. 2001. PMID: 11359658 No abstract available.

9

Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.

de Mendoza C, Lu W, Machuca A, Sainz M, Castilla J, Soriano V. de Mendoza C, et al. J Med Virol. 2001 Jul;64(3):217-22. doi: 10.1002/jmv.1039. J Med Virol. 2001. PMID: 11424107

10

Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families.

de Mendoza C, Martín-Carbonero L, Barreiro P, Diaz B, Valencia E, Jiménez-Nácher I, Gallego O, Núñez M, González-Lahoz J, Soriano V. de Mendoza C, et al. HIV Clin Trials. 2002 Jul-Aug;3(4):304-9. doi: 10.1310/h5jn-mfg3-g35k-qx9j. HIV Clin Trials. 2002. PMID: 12187504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters